Figure 3.

Enhanced β-oxidation of fatty acids and altered lipid signaling cascades is observed in Crohn’s patients, as evidenced by decreasing long-chain fatty acids (A–C) and medium-chain fatty acids (D), as well as increasing acylcarnitine (E–H) in blood circulation. The y-axis measures the peak height of the profiled metabolites, and the x-axis marks the three IBD groups for comparison, namely control (green), inactive (orange), and active (red), outliers, represented as dots, were excluded from comparison. *** p < 0.001, ** p < 0.01, * p < 0.05.